Administration Of Calcium Gluconate for The Reduction of Blood Loss During Elective Cesarean Delivery
Not Applicable
Recruiting
- Conditions
- Elective Cesarean Delivery
- Registration Number
- NCT06235749
- Lead Sponsor
- Rambam Health Care Campus
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 1180
Inclusion Criteria
Inclusion Criteria:<br><br> - Elective Cesarean Delivery, at Gestational age of 35 weeks or more.<br><br>Exclusion Criteria:<br><br> - Age younger than 18 years old.<br><br> - Patients treated with calcium channel blockers.<br><br> - Chronic renal failure and hyperphosphatemia.<br><br> - Sarcoidosis.<br><br> - Hypocalcemia (ionized Ca<1 mmol/L) or hypercalcemia (ionized Ca> 1.3 mmol/L) before<br> the surgery.<br><br> - Any QT abnormalities as evident by ECG before Calcium Gluconate administrations or<br> any known conduction abnormality.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in mean hemoglobin drop
- Secondary Outcome Measures
Name Time Method The rate of women with a decrease of hemoglobin levels of 2 gr/dl or more;additional therapy for the management of PPH;Receipt of blood products.;treatment with intravenous ferrous (iron).;estimated blood loss during the surgery.;Hospitalization length of stay.;Duration of cesarean delivery;A composite of adverse maternal outcomes;Endometritis or antibiotic treatment following CD.